Yuanyue Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yuanyue Zhu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Feika Li
Department of Geriatrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3 shared publications - Kan Wang
Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3 shared publications - Linhui Shen
Department of Geriatrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3 shared publications - Weiguo Hu
Shanghai Jiao Tong University School of Medicine
3 shared publications - Yu Xu
Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3 shared publications - Yufang Bi
Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3 shared publications
Latest Publications
- Open Access
- 17 October 2025
- Published by JMIR Publications Inc. in JMIR Aging
- Vol. 8 (1) , e84642
Correction: Changes in Sarcopenia Status and Subsequent Cardiovascular Outcomes: Prospective Cohort Study
[This corrects the article DOI: .].
- 17 October 2025
- Published by JMIR Publications Inc. in JMIR Aging
- Vol. 8 (1) , e84642
Open AccessCorrection: Changes in Sarcopenia Status and Subsequent Cardiovascular Outcomes: Prospective Cohort Study
[This corrects the article DOI: .].
- Open Access
- 23 September 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Correction: Changes in Sarcopenia Status and Subsequent Cardiovascular Outcomes: Prospective Cohort Study (Preprint)
UNSTRUCTURED Sarcopenia is associated with cardiovascular diseases (CVDs). However, whether the changes in sarcopenia status affect CVD risk remained unclear. Additionally, how indoor fuel use impact the transitions process is less studied. The study prospectively examined the association of sarcopenia transitions with CVD risk, while exploring the effect of indoor fuel on these transitions. The prospective observational study used data from the China Health and Retirement Longitudinal Study (CHARLS) waves 1 to 4 (2011-2018). In total, 8739 participants with full data on sarcopenia and indoor fuel use were included for “indoor fuel use and sarcopenia transition” analysis, and 6385 participants without previous CVDs were included for “sarcopenia transition and CVD risk” analysis. Transition of sarcopenia was defined according to sarcopenia status at wave 1 (2011) and wave 2 (2013). Incident CVD included heart diseases, stroke and composite CVD. Information on indoor fuel were obtained at wave 1. Cox proportional hazards models were conducted to examine the effect of transition in sarcopenia on incident CVD. Logistic regression models were performed to investigate the impact of indoor fuel on these transitions. During a median of 7.0 years follow-up, 1233 incident CVDs were documented. Compared to stably normal participants, progressing from normal to possible or confirmed sarcopenia brought increased risk of incident CVD (hazard ratio (HR):1.42,95% confidence (CI):1.15-1.77). Conversely, recovering to normal state was associated with decreased risk (HR:0.72, 95% CI:0.55-0.95) for baseline possible sarcopenia individuals. Additionally, clean fuel use increased the odds of achieving a possible-to-normal transformation (odds ratio (OR):1.32, 95% CI: 1.06-1.64), while both solid cooking and heating fuel use were associated with higher risk of deterioration in sarcopenia status. Unfavorable transition in sarcopenia status is associated with higher CVD risk, while reversion from possible sarcopenia to normal could reduce the risk. Therefore, early intervention for sarcopenia is imperative for CVD prevention, and promoting clean fuel use is recommended. Not applicable
- 23 September 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessCorrection: Changes in Sarcopenia Status and Subsequent Cardiovascular Outcomes: Prospective Cohort Study (Preprint)
UNSTRUCTURED Sarcopenia is associated with cardiovascular diseases (CVDs). However, whether the changes in sarcopenia status affect CVD risk remained unclear. Additionally, how indoor fuel use impact the transitions process is less studied. The study prospectively examined the association of sarcopenia transitions with CVD risk, while exploring the effect of indoor fuel on these transitions. The prospective observational study used data from the China Health and Retirement Longitudinal Study (CHARLS) waves 1 to 4 (2011-2018). In total, 8739 participants with full data on sarcopenia and indoor fuel use were included for “indoor fuel use and sarcopenia transition” analysis, and 6385 participants without previous CVDs were included for “sarcopenia transition and CVD risk” analysis. Transition of sarcopenia was defined according to sarcopenia status at wave 1 (2011) and wave 2 (2013). Incident CVD included heart diseases, stroke and composite CVD. Information on indoor fuel were obtained at wave 1. Cox proportional hazards models were conducted to examine the effect of transition in sarcopenia on incident CVD. Logistic regression models were performed to investigate the impact of indoor fuel on these transitions. During a median of 7.0 years follow-up, 1233 incident CVDs were documented. Compared to stably normal participants, progressing from normal to possible or confirmed sarcopenia brought increased risk of incident CVD (hazard ratio (HR):1.42,95% confidence (CI):1.15-1.77). Conversely, recovering to normal state was associated with decreased risk (HR:0.72, 95% CI:0.55-0.95) for baseline possible sarcopenia individuals. Additionally, clean fuel use increased the odds of achieving a possible-to-normal transformation (odds ratio (OR):1.32, 95% CI: 1.06-1.64), while both solid cooking and heating fuel use were associated with higher risk of deterioration in sarcopenia status. Unfavorable transition in sarcopenia status is associated with higher CVD risk, while reversion from possible sarcopenia to normal could reduce the risk. Therefore, early intervention for sarcopenia is imperative for CVD prevention, and promoting clean fuel use is recommended. Not applicable
- Open Access
- 8 September 2025
- Published by JMIR Publications Inc. in JMIR Aging
- Vol. 8 (1) , e69860
Changes in Sarcopenia Status and Subsequent Cardiovascular Outcomes: Prospective Cohort Study
Background: Sarcopenia is associated with cardiovascular diseases (CVDs). However, whether changes in sarcopenia status affect CVD risk remains unclear. In addition, how indoor fuel use impacts the sarcopenia transition process is less well studied. Objective: This study prospectively examined the association of sarcopenia transitions with CVD risk, while exploring the effect of indoor fuel on these transitions. Methods: In this prospective observational study, we used data from the China Health and Retirement Longitudinal Study waves 1 to 4 (2011 to 2018). In total, 8739 participants with complete data on sarcopenia and indoor fuel use were included for the indoor fuel use and sarcopenia transition analysis, and 6385 participants without previous CVDs were included for the sarcopenia transition and CVD risk analysis. Sarcopenia transition was defined according to the sarcopenia status at wave 1 (2011) and wave 2 (2013). Incident CVDs included heart diseases, stroke, and composite CVDs. Information on indoor fuel use was obtained at wave 1. Cox proportional hazards models were used to examine the effect of sarcopenia transition on incident CVDs. Logistic regression models were used to investigate the impact of indoor fuel use on these transitions. Results: During a median of 7.0 years of follow-up, 1233 incident CVDs were documented. Compared to stably normal participants, progressing from a normal state to possible or confirmed sarcopenia brought increased risk of incident CVD (hazard ratio 1.42, 95% CI 1.15-1.77). Conversely, recovering to a normal state was associated with decreased risk (hazard ratio 0.72, 95% CI 0.55-0.95) for baseline participants with possible sarcopenia. In addition, clean fuel use increased the odds of achieving a possible-to-normal transformation (odds ratio 1.32, 95% CI 1.06-1.64), while both solid cooking and heating fuel use were associated with a higher risk of deterioration in sarcopenia status. Conclusions: An unfavorable transition in sarcopenia status is associated with higher CVD risk, while reversion from possible sarcopenia to a normal state could reduce the risk. Therefore, early intervention for sarcopenia is imperative for CVD prevention, and promoting clean indoor fuel use is recommended.
- 8 September 2025
- Published by JMIR Publications Inc. in JMIR Aging
- Vol. 8 (1) , e69860
Open AccessChanges in Sarcopenia Status and Subsequent Cardiovascular Outcomes: Prospective Cohort Study
Background: Sarcopenia is associated with cardiovascular diseases (CVDs). However, whether changes in sarcopenia status affect CVD risk remains unclear. In addition, how indoor fuel use impacts the sarcopenia transition process is less well studied. Objective: This study prospectively examined the association of sarcopenia transitions with CVD risk, while exploring the effect of indoor fuel on these transitions. Methods: In this prospective observational study, we used data from the China Health and Retirement Longitudinal Study waves 1 to 4 (2011 to 2018). In total, 8739 participants with complete data on sarcopenia and indoor fuel use were included for the indoor fuel use and sarcopenia transition analysis, and 6385 participants without previous CVDs were included for the sarcopenia transition and CVD risk analysis. Sarcopenia transition was defined according to the sarcopenia status at wave 1 (2011) and wave 2 (2013). Incident CVDs included heart diseases, stroke, and composite CVDs. Information on indoor fuel use was obtained at wave 1. Cox proportional hazards models were used to examine the effect of sarcopenia transition on incident CVDs. Logistic regression models were used to investigate the impact of indoor fuel use on these transitions. Results: During a median of 7.0 years of follow-up, 1233 incident CVDs were documented. Compared to stably normal participants, progressing from a normal state to possible or confirmed sarcopenia brought increased risk of incident CVD (hazard ratio 1.42, 95% CI 1.15-1.77). Conversely, recovering to a normal state was associated with decreased risk (hazard ratio 0.72, 95% CI 0.55-0.95) for baseline participants with possible sarcopenia. In addition, clean fuel use increased the odds of achieving a possible-to-normal transformation (odds ratio 1.32, 95% CI 1.06-1.64), while both solid cooking and heating fuel use were associated with a higher risk of deterioration in sarcopenia status. Conclusions: An unfavorable transition in sarcopenia status is associated with higher CVD risk, while reversion from possible sarcopenia to a normal state could reduce the risk. Therefore, early intervention for sarcopenia is imperative for CVD prevention, and promoting clean indoor fuel use is recommended.